Application of gabapentinoids and novel compounds for the treatment of benzodiazepine dependence: the glutamatergic model

Background Current approaches for managing benzodiazepine (BZD) withdrawal symptoms are daunting for clinicians and patients, warranting novel treatment and management strategies. This review discusses the pharmacodynamic properties of BZDs, gabapentinoids (GBPs), endozepines, and novel GABAergic co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular biology reports 2023-02, Vol.50 (2), p.1765-1784
Hauptverfasser:	Warlick, Halford, Leon, Lexie, Patel, Rudresh, Filoramo, Stefanie, Knipe, Ryan, Joubran, Ernesto, Levy, Arkene, Nguyen, Hoang, Rey, Jose
Format:	Artikel
Sprache:	eng
Schlagworte:	Alcoholism Animal Anatomy Animal Biochemistry Anti-Anxiety Agents - therapeutic use Benzodiazepines Benzodiazepines - pharmacology Benzodiazepines - therapeutic use Biomedical and Life Sciences Biotechnology Case reports Glutamatergic transmission Histology Humans Hypnotics and Sedatives Life Sciences Literature reviews Morphology Patients Pharmacodynamics Review Substance Withdrawal Syndrome - drug therapy Substance-Related Disorders - drug therapy α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid γ-Aminobutyric acid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!